PEL Evidence Review · September 15, 2026 (Pacific)
Ascend BioLabs TB-500 comparison: labels, sizes & COAs
Source-dated TB-500 comparison: specific PEL options, original sample documents, historical Ascend labels and unresolved differences.
Comparison in brief
A blend total cannot establish the amount of a standalone TB-500 offer.
Check the exact TB-500 label and documented sample; similarly named fragments may differ.
Compare the actual label and evidence
| Field | PEL source | Ascend BioLabs source |
|---|---|---|
| Material and labelled amount | TB-500 · 10 mg | TB-500 was named in a catalog category and in the Wolverine blend; a standalone amount was not captured. |
| Source date | Live product identity rechecked September 15, 2026 (Pacific); sample reports retain their own dates. | Original plural-domain homepage captured September 11, 2026. Current product offer not verified. |
| Product options | Separate option links below. | Do not infer a standalone offer from a bundle or a search snippet. |
| Report access | 2 displayed original links; sample matching still required. | No current product-specific original authenticated for this comparison. |
| Current price and stock | Read the exact live PEL option, including checkout terms. | Not established by the archived observation. |
| Next unresolved question | Does the selected option and supplied lot correspond to the document? | Can the supplier provide the current label and its original lot-specific document? |
Choose the exact PEL option
| PEL labelled option | Current product source |
|---|---|
| 10 mg | View this exact PEL option ↗ |
What the original PEL sample document says
TB-500 10mg · TB500016
Report 2606120149 names Freedom Diagnostics and is dated 2026-06-15.
| Field stated by the source | Reported result |
|---|---|
| Identity (LC-MS) | Thymosin Beta-4 |
| Purity (HPLC-UV), analytical-results row | 99.86% |
| Net content average, as printed | 12.04 mg |
The source calls the product TB-500 and the analytical identity Thymosin Beta-4. Retain both terms when evaluating an exact sequence or a fragment claim; this page does not silently treat every similarly named material as interchangeable.
Open the complete original ↗ · Read the full source record and limitations
These are readings of identified sample documents, not a new test, independent laboratory authentication or certification of every current shipping lot.
All displayed originals for this material
Questions answered
Why does the TB-500 source reading mention Thymosin Beta-4?
The original report uses that identity wording. Keep it alongside the product label; a TB-500 name alone does not establish a sequence or justify treating full-length and fragment descriptions as interchangeable.
Does a report prove the current item will be identical?
No. The report describes its identified sample. Check the physical lot, selected amount and supplier documentation before extending the result to an order.
Where can I check the current Ascend website?
Use the dated website-status record. A DNS hold or connection failure does not establish product quality, fraud or an order outcome.
Keep the source and decision together
The historical observation above comes from ascendbiolabs.com, captured September 11, 2026. It is not a finding about the separate singular-name storefront.
Full PEL material guide · All material comparisons · Save a comparison worksheet
Reviewed September 15, 2026 (Pacific). PEL catalog identities were rechecked against the live public catalog. Historical Ascend observations retain their September 11, 2026 capture date; current offers and supplied-lot relationships are not inferred.